Zinc Lozenges Shorten Common Cold Duration by Approximately 2-3 Days
Zinc lozenges at doses ≥75 mg/day, started within 24 hours of cold onset, reduce common cold duration by approximately 2 to 3 days. 1
Evidence from Guidelines
The 2020 European Position Paper on Rhinosinusitis and Nasal Polyps provides Level Ia evidence that zinc administered as zinc acetate or zinc gluconate lozenges at doses ≥75 mg/day significantly reduces the duration of common cold when taken within 24 hours of symptom onset 1. This guideline recommendation is based on systematic review of multiple randomized controlled trials.
Specific Duration Reduction Data
The magnitude of benefit varies across studies but consistently shows meaningful reduction:
Zinc acetate lozenges: One high-quality trial showed reduction in mean cold duration from 7.1 days (placebo) to 4.0 days (zinc), representing a 3.1-day reduction 2
Zinc gluconate lozenges: Studies demonstrated reduction in cough duration by 2.5 to 3 days 3
Pooled analysis: Meta-analyses indicate zinc lozenges reduce cold duration by 33-40% overall, translating to approximately 2.25 to 2.37 days shorter duration 4, 5, 6
Important Nuances About the Effect
The benefit is not uniform across all cold durations. A novel quantile treatment effect analysis revealed that zinc's effect is greater for longer colds: 15-17 day colds were shortened by approximately 8 days, while 2-day colds were shortened by only 1 day 7. This means the average 2-3 day reduction masks substantial variation—patients with more severe, prolonged colds benefit more.
Clinical Implementation
- Dose: 75-92 mg elemental zinc per day (higher doses of 192-207 mg/day show no additional benefit) 4
- Timing: Must start within 24 hours of symptom onset 1
- Duration: Continue throughout the cold 1
- Formulation: Both zinc acetate and zinc gluconate lozenges are effective; no significant difference between salts 4
Side Effects to Balance
The benefit must be weighed against increased risk of adverse events (RR 1.34), primarily bad taste and nausea 6, 1. These are non-serious but common enough to affect tolerability.